HealthSouth Corp (HLS) Given Consensus Recommendation of “Buy” by Analysts
Shares of HealthSouth Corp (NYSE:HLS) have received a consensus rating of “Buy” from the eleven ratings firms that are covering the company. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $47.92.
A number of research analysts recently issued reports on the company. Zacks Investment Research upgraded HealthSouth Corp from a “sell” rating to a “hold” rating in a report on Wednesday, May 3rd. Barclays PLC restated an “underweight” rating and set a $46.00 price target (up previously from $44.00) on shares of HealthSouth Corp in a report on Monday, May 1st. Stephens upgraded HealthSouth Corp from an “equal weight” rating to an “overweight” rating in a report on Wednesday, February 22nd. Mizuho boosted their price target on HealthSouth Corp from $38.00 to $44.50 and gave the company a “neutral” rating in a report on Wednesday, February 22nd. Finally, Royal Bank of Canada boosted their price target on HealthSouth Corp from $48.00 to $50.00 and gave the company an “outperform” rating in a report on Monday, February 27th.
A number of hedge funds have recently bought and sold shares of HLS. Glenview Capital Management LLC purchased a new stake in HealthSouth Corp during the fourth quarter valued at $299,806,000. State Street Corp boosted its stake in HealthSouth Corp by 63.4% in the fourth quarter. State Street Corp now owns 2,924,984 shares of the company’s stock valued at $120,629,000 after buying an additional 1,134,772 shares during the last quarter. Norges Bank purchased a new stake in HealthSouth Corp during the fourth quarter valued at $44,415,000. Wellington Management Group LLP boosted its stake in HealthSouth Corp by 4,377.7% in the first quarter. Wellington Management Group LLP now owns 995,082 shares of the company’s stock valued at $42,599,000 after buying an additional 972,859 shares during the last quarter. Finally, Deprince Race & Zollo Inc. purchased a new stake in HealthSouth Corp during the first quarter valued at $16,129,000. 98.89% of the stock is currently owned by institutional investors and hedge funds.
Shares of HealthSouth Corp (NYSE:HLS) opened at 47.60 on Monday. HealthSouth Corp has a 12 month low of $36.97 and a 12 month high of $47.88. The company has a market cap of $4.26 billion, a price-to-earnings ratio of 17.77 and a beta of 0.85. The company’s 50 day moving average price is $44.49 and its 200 day moving average price is $41.92.
HealthSouth Corp (NYSE:HLS) last announced its quarterly earnings results on Thursday, April 27th. The company reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.05. HealthSouth Corp had a return on equity of 29.27% and a net margin of 6.31%. The company had revenue of $974.80 million for the quarter, compared to the consensus estimate of $960.05 million. During the same quarter in the previous year, the business earned $0.61 EPS. HealthSouth Corp’s revenue was up 7.1% compared to the same quarter last year. On average, equities analysts expect that HealthSouth Corp will post $2.70 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 17th. Shareholders of record on Monday, July 3rd will be given a dividend of $0.24 per share. The ex-dividend date is Thursday, June 29th. This represents a $0.96 annualized dividend and a yield of 2.02%. HealthSouth Corp’s payout ratio is 40.17%.
About HealthSouth Corp
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with MarketBeat.com's FREE daily email newsletter.